Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 4, 2005, Pages 856-863

  Jabara, Haifa H ^a   Geha, Raif S ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

B cells; CD40; Isotype switching; Jun terminal kinase

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CD23 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD86 ANTIGEN; DEAMINASE; ENZYME INHIBITOR; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL XL; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; DIGESTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 16244374879     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.01.020     Document Type: Article

References (59)

1. L.B. Bacharier, H. Jabara, and R.S. Geha Molecular mechanisms of immunoglobulin E regulation Int Arch Allergy Immunol 115 1998 257 269
2. R.S. Geha, H.H. Jabara, and S.R. Brodeur The regulation of immunoglobulin E class-switch recombination Nat Rev Immunol 3 2003 721 732
3. J. Banchereau, F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, and C. van Kooten The CD40 antigen and its ligand Annu Rev Immunol 12 1994 881 922
4. H.H. Jabara, S.M. Fu, R.S. Geha, and D. Vercelli CD40 and IgE: synergism between anti-CD40 mAb and IL-4 in the induction of IgE synthesis by highly purified human B cells J Exp Med 172 1990 1861 1864
5. R. Fuleihan, N. Ramesh, R. Loh, H. Jabara, F.S. Rosen, and T. Chatila Defective expression of the CD40 ligand in X-chromosome linked immunoglobulin deficiency with normal or elevated IgM Proc Natl Acad Sci U S A 90 1993 2170 2173
6. E. Castigli, F. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, and A.K. Bhan CD40 deficient mice generated by RAG-2 deficient blastocyst complementation Proc Natl Acad Sci U S A 91 1994 12135 12139
7. T. Kawabe, T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, and S. Suematsu The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation Immunity 1 1994 167 178
8. J. Xu, T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, and T.J. Waldschmidt Mice deficient for the CD40 ligand Immunity 1 1994 423 431
9. S.S. Pullen, H.G. Miller, D.S. Everdeen, T.T. Dang, J.J. Crute, and M.R. Kehry CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization Biochemistry 37 1998 11836 11845
10. G. Cheng, A.M. Cleary, Z. Ye, D.I. Hong, S. Lederman, and D. Baltimore Involvement of CRAF1, a relative of TRAF, in CD40 signaling Science 267 1995 1494 1498
11. C.L. Sutherland, D.L. Krebs, and M.R. Gold An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest J Immunol 162 1999 4720 4730
12. H.H. Lee, P.W. Dempsey, T.P. Parks, X. Zhu, D. Baltimore, and G. Cheng Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation Proc Natl Acad Sci U S A 96 1999 1421 1426
13. Y.Y. Li, M. Baccam, S.B. Waters, J.E. Pessin, G.A. Bishop, and G.A. Koretzky CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells J Immunol 157 1996 1440 1447
14. I. Berberich, G.L. Shu, and E.A. Clark Cross-linking CD40 on B cells rapidly activates nuclear factor-κB J Immunol 153 1994 4357 4366
15. L.A. Iciek, S.A. Delphin, and J. Stavnezer CD40 cross-linking induces Ig epsilon germline transcripts in B cells via activation of NF-kappaB: synergy with IL-4 induction J Immunol 158 1997 4769 4779
16. C.L. Sutherland, A.W. Heath, S.L. Pelech, P.R. Young, and M.R. Gold Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor J Immunol 157 1996 3381 3390
17. N. Sakata, H. Kawasome, N. Terada, P. Gerwins, G.L. Johnson, and E.W. Gelfand Differential activation and regulation of mitogen-activated protein kinases through the antigen receptor and CD40 in human B cells Eur J Immunol 29 1999 2999 3008
18. M. Kashiwada, Y. Shirakata, J.I. Inoue, H. Nakano, K. Okazaki, and K. Okumura Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway J Exp Med 187 1998 237 244
19. H. Jabara, D. Laouini, E. Tsitsikov, E. Mizoguchi, A. Bhan, and E. Castigli The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching Immunity 17 2002 265 276
20. M.L. Richards, and D.H. Katz Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine Fc epsilon RII (CD23): comparison with the germline epsilon promoter J Immunol 158 1997 263 272
21. F. Dedeoglu, B. Horwitz, J. Chaudhuri, F.W. Alt, and R.S. Geha Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB Int Immunol 16 2004 395 404
22. B.H. Horwitz, P. Zelazowski, Y. Shen, K.M. Wolcott, M.L. Scott, and D. Baltimore The p65 subunit of NF-kappa B is redundant with p50 during B cell proliferative responses, and is required for germline CH transcription and class switching to IgG3 J Immunol 162 1999 1941 1946
23. A. Jain, C.A. Ma, S. Liu, M. Brown, J. Cohen, and W. Strober Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia Nat Immunol 2 2001 223 228
24. R. Doffinger, A. Smahi, C. Bessia, F. Geissmann, J. Feinberg, and A. Durandy X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling Nat Genet 27 2001 277 285
25. K. Zhang, L. Zhang, D. Zhu, D. Bae, A. Nel, and A. Saxon CD40-mediated p38 mitogen-activated protein kinase activation is required for immunoglobulin class switch recombination to IgE J Allergy Clin Immunol 110 2002 421 428
26. K. Brady, S. Fitzgerald, S. Ingvarsson, C.A. Borrebaeck, and P.N. Moynagh CD40 employs p38 MAP kinase in IgE isotype switching Biochem Biophys Res Commun 289 2001 276 281
27. B.L. Bennett, D.T. Sasaki, B.W. Murray, E.C. O'Leary, S.T. Sakata, and W. Xu SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase Proc Natl Acad Sci U S A 98 2001 13681 13686
28. C.C. Chu, W.E. Paul, and E.E. Max Quantitation of immunoglobulin μ-γ1 heavy chain switch region recombination by a digestion- circularization polymerase chain reaction Proc Natl Acad Sci U S A 89 1992 6978 6982
29. L. Xu, and P. Rothman IFN-gamma represses epsilon germline transcription and subsequently down-regulates switch recombination to epsilon Int Immunol 6 1994 515 521
30. A. Aicher, G.L. Shu, D. Magaletti, T. Mulvania, A. Pezzutto, and A. Craxton Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells J Immunol 163 1999 5786 5795
31. W.C. Sha Regulation of immune responses by NF-kappa B/Rel transcription factor J Exp Med 187 1998 143 146
32. H. Dadgostar, B. Zarnegar, A. Hoffmann, X.F. Qin, U. Truong, and G. Rao Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes Proc Natl Acad Sci U S A 99 2002 1497 1502
33. J. Hasbold, A.B. Lyons, M.R. Kehry, and P.D. Hodgkin Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4 Eur J Immunol 28 1998 1040 1051
34. J.P. Manis, M. Tian, and F.W. Alt Mechanism and control of class-switch recombination Trends Immunol 23 2002 31 39
35. Z. Han, D.L. Boyle, L. Chang, B. Bennett, M. Karin, and L. Yang c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis J Clin Invest 108 2001 73 81
36. H. Dadgostar, and G. Cheng An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling J Biol Chem 273 1998 24775 24780
37. I. Sanchez-Perez, S.A. Benitah, M. Martinez-Gomariz, J.C. Lacal, and R. Perona Cell stress and MEKK1-mediated c-Jun activation modulate NFkappaB activity and cell viability Mol Biol Cell 13 2002 2933 2945
38. S. Park, E.R. Hahm, D.K. Lee, and C.H. Yang Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells J Cell Biochem 91 2004 973 986
39. J.D. Graves, K.E. Draves, A. Craxton, J. Saklatvala, E.G. Krebs, and E.A. Clark Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes Proc Natl Acad Sci U S A 93 1996 13814 13818
40. C.S. Shi, and J.H. Kehrl Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-kappaB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway J Biol Chem 272 1997 32102 32107
41. E. Takada, H. Toyota, J. Suzuki, and J. Mizuguchi Prevention of anti-IgM-induced apoptosis accompanying G1 arrest in B lymphoma cells overexpressing dominant-negative mutant form of c-Jun N-terminal kinase 1 J Immunol 166 2001 1641 1649
42. D.E. Muscarella, and S.E. Bloom Differential activation of the c-Jun N-terminal kinase pathway in arsenite-induced apoptosis and sensitization of chemically resistant compared to susceptible B-lymphoma cell lines Toxicol Sci 68 2002 82 92
43. P. Hess, G. Pihan, C.L. Sawyers, R.A. Flavell, and R.J. Davis Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts Nat Genet 32 2002 201 205
44. W. Lim, W. Ma, K. Gee, S. Aucoin, D. Nandan, and F. Diaz-Mitoma Distinct role of p38 and c-Jun N-terminal kinases in IL-10-dependent and IL-10-independent regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells J Immunol 168 2002 1759 1769
45. H.L. Liao, Y. Zhu, N. Wang, L. Verna, and M.B. Stemerman Selective activation of endothelial cells by the antioxidant pyrrolidine dithiocarbamate: involvement of C-jun N-terminal kinase and AP-1 activation Endothelium 7 2000 121 133
46. K.A. Roebuck Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB Int J Mol Med 4 1999 223 230
47. N. Wang, L. Verna, S. Hardy, J. Forsayeth, Y. Zhu, and M.B. Stemerman Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells Arterioscler Thromb Vasc Biol 19 1999 2078 2084
48. K. Sabapathy, T. Kallunki, J.P. David, I. Graef, M. Karin, and E.F. Wagner c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation J Exp Med 193 2001 317 328
49. M. Muramatsu, V.S. Sankaranand, S. Anant, M. Sugai, K. Kinoshita, and N.O. Davidson Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells J Biol Chem 274 1999 18470 18476
50. J. Chaudhuri, M. Tian, C. Khuong, K. Chua, E. Pinaud, and F.W. Alt Transcription-targeted DNA deamination by the AID antibody diversification enzyme Nature 422 2003 726 730
51. P. Revy, T. Muto, Y. Levy, F. Geissmann, A. Plebani, and O. Sanal Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2) Cell 102 2000 565 575
52. K. Imai, G. Slupphaug, W.I. Lee, P. Revy, S. Nonoyama, and N. Catalan Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination Nat Immunol 4 2003 1023 1028
53. M. Muramatsu, K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme Cell 102 2000 553 563
54. C. Rada, G.T. Williams, H. Nilsen, D.E. Barnes, T. Lindahl, and M.S. Neuberger Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice Curr Biol 12 2002 1748 1755
55. J. Chaudhuri, C. Khuong, and F.W. Alt Replication protein A interacts with AID to promote deamination of somatic hypermutation targets Nature 430 2004 992 998
56. V.T. Ta, H. Nagaoka, N. Catalan, A. Durandy, A. Fischer, and K. Imai AID mutant analyses indicate requirement for class-switch-specific cofactors Nat Immunol 4 2003 843 848
57. T. Honjo Does AID need another aid? Nat Immunol 3 2002 800 801
58. J.P. Manis, J.C. Morales, Z. Xia, J.L. Kutok, F.W. Alt, and P.B. Carpenter 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination Nat Immunol 5 2004 481 487
59. J. Hayakawa, C. Depatie, M. Ohmichi, and D. Mercola The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair J Biol Chem 278 2003 20582 20592